Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pfizer Inc (PFE) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pfizer Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 78003.
Total stock buying since 2005: $1,953,464.
Total stock sales since 2005: $363,276,548.
Total stock option exercises since 2005: $612,393,708.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 19,457 | $499,072 | 2,500 | $64,825 | 2,424,938 | $75,547,913 |
2024 | 1,000 | $28,240 | 5,154 | $147,713 | 360,145 | $9,846,361 |
2023 | 5,000 | $156,406 | 9,912 | $396,678 | 344,694 | $9,372,285 |
2022 | 0 | $0 | 144,709 | $7,188,850 | 730,491 | $20,011,756 |
2021 | 0 | $0 | 387,163 | $19,952,499 | 1,733,598 | $40,810,764 |
2020 | 14,000 | $538,407 | 367,010 | $14,617,887 | 1,206,384 | $37,688,196 |
2019 | 3,000 | $104,160 | 1,128,341 | $48,918,114 | 4,095,964 | $96,886,509 |
2018 | 0 | $0 | 1,276,366 | $47,938,736 | 4,671,282 | $115,823,336 |
2017 | 0 | $0 | 644,287 | $22,038,040 | 1,695,997 | $35,666,813 |
2016 | 1,566 | $51,427 | 997,443 | $33,663,651 | 2,458,189 | $51,536,405 |
2015 | 0 | $0 | 497,351 | $17,181,381 | 1,229,800 | $23,376,238 |
2014 | 0 | $0 | 679,712 | $21,093,197 | 1,530,892 | $22,864,980 |
2013 | 758 | $22,050 | 1,269,126 | $37,544,645 | 1,288,312 | $31,322,547 |
2012 | 0 | $0 | 190,175 | $4,594,239 | 100,000 | $1,747,000 |
2011 | 100 | $1,905 | 49,991 | $969,973 | 0 | $0 |
2010 | 549 | $9,947 | 28,060 | $446,196 | 0 | $0 |
2009 | 0 | $0 | 190,322 | $2,987,431 | 206,475 | $0 |
2008 | 15,500 | $317,850 | 24,505 | $467,424 | 0 | $0 |
2007 | 500 | $12,000 | 585,897 | $15,507,638 | 259,404 | $4,760,062 |
2006 | 0 | $0 | 2,368,664 | $61,823,677 | 2,397,966 | $35,132,543 |
2005 | 10,000 | $212,000 | 210,871 | $5,733,754 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-03 | 0 | $0 | 2,500 | $64,825 | 0 | $0 |
2025-02 | 19,457 | $499,072 | 0 | $0 | 2,424,938 | $75,547,913 |
2024-10 | 1,000 | $28,240 | 0 | $0 | 0 | $0 |
2024-08 | 0 | $0 | 5,154 | $147,713 | 0 | $0 |
2024-02 | 0 | $0 | 0 | $0 | 360,145 | $9,846,361 |
2023-12 | 3,000 | $79,401 | 0 | $0 | 0 | $0 |
2023-05 | 2,000 | $77,005 | 0 | $0 | 0 | $0 |
2023-03 | 0 | $0 | 9,912 | $396,678 | 0 | $0 |
2023-02 | 0 | $0 | 0 | $0 | 344,694 | $9,372,285 |
2022-06 | 0 | $0 | 4,218 | $227,603 | 0 | $0 |
2022-05 | 0 | $0 | 140,491 | $6,961,247 | 0 | $0 |
2022-03 | 0 | $0 | 0 | $0 | 102,460 | $3,383,741 |
2022-02 | 0 | $0 | 0 | $0 | 628,031 | $16,628,015 |
2021-12 | 0 | $0 | 60,360 | $3,259,477 | 194,242 | $5,404,976 |
2021-11 | 0 | $0 | 320,142 | $16,403,605 | 199,548 | $5,043,974 |
2021-08 | 0 | $0 | 1,661 | $80,217 | 0 | $0 |
2021-07 | 0 | $0 | 2,500 | $107,150 | 0 | $0 |
2021-05 | 0 | $0 | 2,500 | $102,050 | 0 | $0 |
2021-02 | 0 | $0 | 0 | $0 | 1,339,808 | $30,361,814 |
2020-11 | 0 | $0 | 176,170 | $7,388,569 | 0 | $0 |
2020-08 | 13,000 | $501,410 | 0 | $0 | 0 | $0 |
2020-06 | 0 | $0 | 2,181 | $78,799 | 0 | $0 |
2020-05 | 0 | $0 | 95,353 | $3,602,913 | 0 | $0 |
2020-04 | 0 | $0 | 93,306 | $3,547,606 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-04 | Damico Jennifer B. (SVP & Controller) | Sale | 2,500 | 25.93 | 64,825 |
2025-02-27 | Mcdermott Michael (Executive Vice President) | Option Ex | 48,419 | 31.31 | 1,515,998 |
2025-02-27 | Sahni Payal (Executive Vice President) | Option Ex | 342,972 | 31.31 | 10,738,440 |
2025-02-27 | Damico Jennifer B. (SVP & Controller) | Option Ex | 22,416 | 31.31 | 701,844 |
2025-02-27 | Bourla Albert (Chairman & CEO) | Option Ex | 582,823 | 31.31 | 18,248,188 |
2025-02-27 | Lankler Douglas M (Executive Vice President) | Option Ex | 313,828 | 31.31 | 9,825,954 |
2025-02-27 | Fonseca Lidia (Executive Vice President) | Option Ex | 145,258 | 31.31 | 4,548,026 |
2025-02-27 | Susman Sally (Executive Vice President) | Option Ex | 85,182 | 31.31 | 2,667,048 |
2025-02-22 | Boshoff Christoffel (President, R&D) | Option Ex | 8,741 | 30.17 | 263,715 |
2025-02-22 | Mcdermott Michael (Executive Vice President) | Option Ex | 11,125 | 30.17 | 335,641 |
2025-02-22 | Damico Jennifer B. (SVP & Controller) | Option Ex | 8,741 | 30.17 | 263,715 |
2025-02-22 | Bourla Albert (Chairman & CEO) | Option Ex | 238,399 | 30.17 | 7,192,497 |
2025-02-22 | Susman Sally (Executive Vice President) | Option Ex | 63,573 | 30.17 | 1,917,997 |
2025-02-13 | Blaylock Ronald E (Director) | Buy | 19,457 | 25.65 | 499,072 |
2024-10-30 | Gottlieb Scott (Director) | Buy | 1,000 | 28.24 | 28,240 |
2024-08-13 | Damico Jennifer B. (SVP & Controller) | Sale | 5,154 | 28.66 | 147,713 |
2024-02-23 | Boshoff Christoffel (Executive Vice President) | Option Ex | 9,752 | 27.34 | 266,619 |
2024-02-23 | Mcdermott Michael (Executive Vice President) | Option Ex | 12,412 | 27.34 | 339,344 |
2024-02-23 | Sahni Payal (Executive Vice President) | Option Ex | 11,527 | 27.34 | 315,148 |
2024-02-23 | Damico Jennifer B. (SVP & Controller) | Option Ex | 9,752 | 27.34 | 266,619 |
2024-02-23 | Bourla Albert (Chairman & CEO) | Option Ex | 127,674 | 27.34 | 3,490,607 |
2024-02-23 | Johnson Rady A (Executive Vice President) | Option Ex | 29,436 | 27.34 | 804,780 |
2024-02-23 | Lankler Douglas M (Executive Vice President) | Option Ex | 95,755 | 27.34 | 2,617,941 |
2024-02-23 | Susman Sally (Executive Vice President) | Option Ex | 63,837 | 27.34 | 1,745,303 |
2023-12-15 | Gottlieb Scott (Director) | Buy | 3,000 | 26.47 | 79,401 |
2023-05-08 | Gottlieb Scott (Director) | Buy | 1,000 | 38.58 | 38,580 |
2023-05-05 | Gottlieb Scott (Director) | Buy | 1,000 | 38.42 | 38,425 |
2023-03-15 | Damico Jennifer B. (SVP & Controller) | Sale | 9,912 | 40.02 | 396,678 |
2023-02-25 | Mcdermott Michael (Executive Vice President) | Option Ex | 14,178 | 22.89 | 324,534 |
2023-02-25 | Hwang Angela (President, Global Biopharma) | Option Ex | 20,273 | 22.89 | 464,048 |
2023-02-25 | Johnson Rady A (Executive Vice President) | Option Ex | 33,654 | 22.89 | 770,340 |
2023-02-25 | Susman Sally (Executive Vice President) | Option Ex | 72,984 | 22.89 | 1,670,603 |
2023-02-22 | Mcdermott Michael (Executive Vice President) | Option Ex | 13,307 | 30.17 | 401,472 |
2023-02-22 | Sahni Payal (Executive Vice President) | Option Ex | 15,209 | 30.17 | 458,855 |
2023-02-22 | Damico Jennifer B. (SVP & Controller) | Option Ex | 10,456 | 30.17 | 315,457 |
2023-02-22 | Hwang Angela (President, Global Biopharmaceu) | Option Ex | 57,032 | 30.17 | 1,720,655 |
2023-02-22 | Johnson Rady A (Executive Vice President) | Option Ex | 31,558 | 30.17 | 952,104 |
2023-02-22 | Susman Sally (Executive Vice President) | Option Ex | 76,043 | 30.17 | 2,294,217 |
2022-06-07 | Damico Jennifer B. (SVP & Controller) | Sale | 4,218 | 53.96 | 227,603 |
2022-05-16 | Damico Jennifer B. (SVP & Controller) | Sale | 4,000 | 50.50 | 202,000 |
2022-05-13 | Sahni Payal (Executive Vice President) | Sale | 1,408 | 49.84 | 70,174 |
2022-05-12 | Lankler Douglas M (Executive Vice President) | Sale | 38,273 | 49.41 | 1,891,068 |
2022-05-12 | Carapezzi William R Jr (Executive Vice President) | Sale | 32,908 | 50.00 | 1,645,400 |
2022-05-11 | Dolsten Mikael (President R&D) | Sale | 63,902 | 49.34 | 3,152,605 |
2022-03-03 | Dolsten Mikael (President R&D) | Option Ex | 102,460 | 33.02 | 3,383,741 |
2022-02-26 | Mcdermott Michael (Executive Vice President) | Option Ex | 12,340 | 25.60 | 315,904 |
2022-02-26 | Damico Jennifer B. (SVP & Controller) | Option Ex | 9,713 | 25.60 | 248,652 |
2022-02-26 | Lankler Douglas M (Executive Vice President) | Option Ex | 77,709 | 25.60 | 1,989,350 |
2022-02-26 | Carapezzi William R Jr (Executive Vice President) | Option Ex | 21,193 | 25.60 | 542,540 |
2022-02-26 | Susman Sally (Executive Vice President) | Option Ex | 63,580 | 25.60 | 1,627,648 |
2022-02-26 | Damelio Frank A (Executive Vice President) | Option Ex | 127,160 | 25.60 | 3,255,296 |
2022-02-23 | Damico Jennifer B. (SVP & Controller) | Option Ex | 11,748 | 27.34 | 321,190 |
2022-02-23 | Johnson Rady A (Executive Vice President) | Option Ex | 35,457 | 27.34 | 969,394 |
2022-02-23 | Lankler Douglas M (Executive Vice President) | Option Ex | 115,342 | 27.34 | 3,153,450 |
2022-02-23 | Damelio Frank A (Executive Vice President) | Option Ex | 153,789 | 27.34 | 4,204,591 |
2021-12-17 | Bourla Albert (Chairman & CEO) | Option Ex | 123,055 | 26.47 | 3,257,265 |
2021-12-17 | Dolsten Mikael (President R&D) | Option Ex | 71,187 | 30.17 | 2,147,711 |
2021-12-03 | Johnson Rady A (Executive Vice President) | Sale | 19,000 | 53.44 | 1,015,284 |
2021-12-02 | Mackenzie Alexander R (Executive Vice President) | Sale | 41,360 | 54.26 | 2,244,193 |
2021-11-26 | Lankler Douglas M (Executive Vice President) | Sale | 40,000 | 54.38 | 2,175,280 |
2021-11-26 | Susman Sally (Executive Vice President) | Sale | 44,308 | 54.52 | 2,415,627 |
2021-11-12 | Hwang Angela (Group President) | Sale | 26,170 | 49.60 | 1,298,162 |
2021-11-11 | Young John D (Group President) | Sale | 150,000 | 50.09 | 7,512,900 |
2021-11-11 | Dolsten Mikael (President R&D) | Sale | 59,664 | 50.31 | 3,001,636 |
2021-11-11 | Dolsten Mikael (President R&D) | Option Ex | 199,548 | 25.28 | 5,043,974 |
2021-08-13 | Damico Jennifer B. (SVP & Controller) | Sale | 1,661 | 48.30 | 80,217 |
2021-07-30 | Damico Jennifer B. (SVP & Controller) | Sale | 2,500 | 42.86 | 107,150 |
2021-05-05 | Damico Jennifer B. (SVP & Controller) | Sale | 2,500 | 40.82 | 102,050 |
2021-02-27 | Damico Jennifer B. (SVP & Controller) | Option Ex | 9,886 | 22.35 | 220,952 |
2021-02-27 | Hwang Angela (Group President) | Option Ex | 9,886 | 22.35 | 220,952 |
2021-02-27 | Mackenzie Alexander R (Executive Vice President) | Option Ex | 29,838 | 22.35 | 666,879 |
2021-02-27 | Bourla Albert (Chairman & CEO) | Option Ex | 53,925 | 22.35 | 1,205,223 |
2021-02-27 | Johnson Rady A (Executive Vice President) | Option Ex | 25,165 | 22.35 | 562,437 |
2021-02-27 | Young John D (Group President) | Option Ex | 129,419 | 22.35 | 2,892,514 |
2021-02-27 | Lankler Douglas M (Executive Vice President) | Option Ex | 53,925 | 22.35 | 1,205,223 |
2021-02-27 | Carapezzi William R Jr (Executive Vice President) | Option Ex | 21,570 | 22.35 | 482,089 |
2021-02-27 | Susman Sally (Executive Vice President) | Option Ex | 71,899 | 22.35 | 1,606,942 |
2021-02-27 | Damelio Frank A (Executive Vice President) | Option Ex | 152,785 | 22.35 | 3,414,744 |
2021-02-25 | Sahni Payal (Executive Vice President) | Option Ex | 9,982 | 22.89 | 228,487 |
2021-02-25 | Damico Jennifer B. (SVP & Controller) | Option Ex | 12,477 | 22.89 | 285,598 |
2021-02-25 | Hwang Angela (Group President) | Option Ex | 22,686 | 22.89 | 519,282 |
2021-02-25 | Bourla Albert (Chairman & CEO) | Option Ex | 163,334 | 22.86 | 3,733,815 |
2021-02-25 | Johnson Rady A (Executive Vice President) | Option Ex | 37,658 | 22.89 | 861,991 |
2021-02-25 | Young John D (Group President) | Option Ex | 163,334 | 22.89 | 3,738,715 |
2021-02-25 | Lankler Douglas M (Executive Vice President) | Option Ex | 99,816 | 22.89 | 2,284,788 |
2021-02-25 | Carapezzi William R Jr (Executive Vice President) | Option Ex | 27,222 | 22.89 | 623,111 |
2021-02-25 | Susman Sally (Executive Vice President) | Option Ex | 81,667 | 22.89 | 1,869,357 |
2021-02-25 | Damelio Frank A (Executive Vice President) | Option Ex | 163,334 | 22.89 | 3,738,715 |
2020-11-09 | Bourla Albert (Chairman & CEO) | Sale | 132,508 | 41.94 | 5,557,385 |
2020-11-09 | Susman Sally (Executive Vice President) | Sale | 43,662 | 41.94 | 1,831,184 |
2020-08-06 | Blaylock Ronald E (Director) | Buy | 13,000 | 38.57 | 501,410 |
2020-06-05 | Damico Jennifer B. (SVP & Controller) | Sale | 2,181 | 36.13 | 78,799 |
2020-05-18 | Dolsten Mikael (President R&D) | Sale | 95,353 | 37.78 | 3,602,913 |
2020-04-29 | Damico Jennifer B. (SVP & Controller) | Sale | 2,181 | 38.35 | 83,641 |
2020-04-29 | Rogers Dawn (Executive Vice President) | Sale | 13,000 | 38.13 | 495,690 |
2020-04-29 | Johnson Rady A (Executive Vice President) | Sale | 13,125 | 38.36 | 503,475 |
2020-04-29 | Lankler Douglas M (Executive Vice President) | Sale | 65,000 | 37.92 | 2,464,800 |
2020-02-28 | Goettler Michael (Group President) | Option Ex | 22,852 | 27.37 | 625,459 |
2020-02-28 | Rogers Dawn (Executive Vice President) | Option Ex | 17,824 | 27.37 | 487,842 |
2020-02-28 | Mackenzie Alexander R (Executive Vice President) | Option Ex | 37,934 | 27.37 | 1,038,253 |
2020-02-28 | Bourla Albert (Chairman & CEO) | Option Ex | 33,135 | 27.37 | 906,904 |
2020-02-28 | Johnson Rady A (Executive Vice President) | Option Ex | 15,996 | 27.37 | 437,810 |
2020-02-28 | Young John D (Group President) | Option Ex | 100,548 | 27.37 | 2,751,998 |
2020-02-28 | Lankler Douglas M (Executive Vice President) | Option Ex | 38,848 | 27.37 | 1,063,269 |
2020-02-28 | Susman Sally (Executive Vice President) | Option Ex | 91,408 | 27.37 | 2,501,836 |
2020-02-28 | Damelio Frank A (Executive Vice President) | Option Ex | 173,675 | 27.37 | 4,753,484 |
2020-02-28 | Cangialosi Loretta V (Sr. Vice President, Controller) | Option Ex | 27,422 | 27.37 | 750,540 |
2020-02-26 | Goettler Michael (Group President) | Option Ex | 20,129 | 34.59 | 696,262 |
2020-02-26 | Rogers Dawn (Executive Vice President) | Option Ex | 15,097 | 34.59 | 522,205 |
2020-02-26 | Hwang Angela (Group President) | Option Ex | 14,493 | 34.59 | 501,312 |
2020-02-26 | Bourla Albert (Chairman & CEO) | Option Ex | 88,567 | 34.59 | 3,063,532 |
2020-02-26 | Johnson Rady A (Executive Vice President) | Option Ex | 33,414 | 34.59 | 1,155,790 |
2020-02-26 | Young John D (Group President) | Option Ex | 144,928 | 34.59 | 5,013,059 |
2020-02-26 | Lankler Douglas M (Executive Vice President) | Option Ex | 88,567 | 34.59 | 3,063,532 |
2020-02-26 | Susman Sally (Executive Vice President) | Option Ex | 72,464 | 34.59 | 2,506,529 |
2020-02-26 | Damelio Frank A (Executive Vice President) | Option Ex | 144,928 | 34.59 | 5,013,059 |
2020-02-26 | Cangialosi Loretta V (Sr. Vice President, Controller) | Option Ex | 24,155 | 34.59 | 835,521 |
2020-01-30 | Gottlieb Scott (Director) | Buy | 1,000 | 37.00 | 36,997 |
2019-08-23 | Gottlieb Scott (Director) | Buy | 3,000 | 34.72 | 104,160 |
2019-07-02 | Damelio Frank A (Executive Vice President) | Sale | 153,184 | 44.09 | 6,754,648 |
2019-06-20 | Mackenzie Alexander R (Executive Vice President) | Sale | 30,000 | 44.00 | 1,320,000 |
2019-04-01 | Mackenzie Alexander R (Executive Vice President) | Sale | 15,000 | 42.80 | 642,015 |
2019-03-15 | Johnson Rady A (Executive Vice President) | Sale | 8,700 | 41.13 | 357,831 |
2019-03-04 | Rogers Dawn (Executive Vice President) | Sale | 15,002 | 42.98 | 644,860 |
2019-03-04 | Dolsten Mikael (President R&D) | Sale | 49,082 | 43.54 | 2,137,030 |
2019-03-04 | Read Ian C (Executive Chairman) | Sale | 580,866 | 43.29 | 25,155,928 |
2019-03-04 | Susman Sally (Executive Vice President) | Sale | 72,723 | 43.23 | 3,141,339 |
2019-03-01 | Dolsten Mikael (President R&D) | Sale | 100,471 | 43.58 | 4,378,023 |
2019-03-01 | Dolsten Mikael (President R&D) | Option Ex | 106,191 | 31.41 | 3,335,459 |
2019-02-27 | Goettler Michael (Group President) | Option Ex | 30,017 | 32.23 | 967,447 |
2019-02-27 | Rogers Dawn (Executive Vice President) | Option Ex | 19,297 | 32.23 | 621,942 |
2019-02-27 | Hwang Angela (Group President) | Option Ex | 11,792 | 32.23 | 380,056 |
2019-02-27 | Bourla Albert (Chief Executive Officer) | Option Ex | 64,322 | 32.23 | 2,073,098 |
2019-02-27 | Johnson Rady A (Executive Vice President) | Option Ex | 30,017 | 32.23 | 967,447 |
2019-02-27 | Young John D (Group President) | Option Ex | 154,374 | 32.23 | 4,975,474 |
2019-02-27 | Lankler Douglas M (Executive Vice President) | Option Ex | 64,322 | 32.23 | 2,073,098 |
2019-02-27 | Lewis-hall Freda C (Executive Vice President) | Option Ex | 81,475 | 32.23 | 2,625,939 |
2019-02-27 | Susman Sally (Executive Vice President) | Option Ex | 85,763 | 32.23 | 2,764,141 |
2019-02-27 | Damelio Frank A (Executive Vice President) | Option Ex | 182,247 | 32.23 | 5,873,820 |
2019-02-27 | Cangialosi Loretta V (Sr. Vice President, Controller) | Option Ex | 25,729 | 32.23 | 829,245 |
2019-02-23 | Goettler Michael (Group President) | Option Ex | 57,870 | 21.03 | 1,217,004 |
2019-02-23 | Rogers Dawn (Executive Vice President) | Option Ex | 57,870 | 21.03 | 1,217,004 |
2019-02-23 | Mackenzie Alexander R (Executive Vice President) | Option Ex | 124,845 | 21.03 | 2,625,489 |
2019-02-23 | Bourla Albert (Chief Executive Officer) | Option Ex | 108,024 | 21.03 | 2,271,744 |
2019-02-23 | Johnson Rady A (Executive Vice President) | Option Ex | 54,012 | 21.03 | 1,135,872 |
2019-02-23 | Young John D (Group President) | Option Ex | 131,172 | 21.03 | 2,758,545 |
2019-02-23 | Lankler Douglas M (Executive Vice President) | Option Ex | 131,172 | 21.03 | 2,758,545 |
2019-02-23 | Lewis-hall Freda C (Executive Vice President) | Option Ex | 262,347 | 21.03 | 5,517,156 |
2019-02-23 | Susman Sally (Executive Vice President) | Option Ex | 293,211 | 21.03 | 6,166,227 |
2019-02-23 | Damelio Frank A (Executive Vice President) | Option Ex | 555,555 | 21.03 | 11,683,320 |
Insider trading activities including stock purchases, stock sales, and option exercises of PFE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pfizer Inc (symbol PFE, CIK number 78003) see the Securities and Exchange Commission (SEC) website.